Manke H, Nunn S, Sulima A, Rice K, Riley A
Brain Sci. 2023; 13(9).
PMID: 37759895
PMC: 10526358.
DOI: 10.3390/brainsci13091294.
Taffe M, Nguyen J, Vandewater S, Grant Y, Dickerson T
Drug Alcohol Depend. 2021; 227:108910.
PMID: 34332176
PMC: 9812683.
DOI: 10.1016/j.drugalcdep.2021.108910.
Patocka J, Zhao B, Wu W, Klimova B, Valis M, Nepovimova E
Int J Mol Sci. 2020; 21(21).
PMID: 33142953
PMC: 7663692.
DOI: 10.3390/ijms21218185.
Schindler C, Thorndike E, Walters H, Walther D, Rice K, Baumann M
Addict Biol. 2019; 25(6):e12842.
PMID: 31724254
PMC: 7217742.
DOI: 10.1111/adb.12842.
Hall F, Miczek K
Psychopharmacology (Berl). 2019; 236(3):839-843.
PMID: 31119328
DOI: 10.1007/s00213-019-05271-7.
Abuse potential and toxicity of the synthetic cathinones (i.e., "Bath salts").
Riley A, Nelson K, To P, Lopez-Arnau R, Xu P, Wang D
Neurosci Biobehav Rev. 2019; 110:150-173.
PMID: 31101438
PMC: 8617600.
DOI: 10.1016/j.neubiorev.2018.07.015.
The abuse-related effects of pyrrolidine-containing cathinones are related to their potency and selectivity to inhibit the dopamine transporter.
Gannon B, Baumann M, Walther D, Jimenez-Morigosa C, Sulima A, Rice K
Neuropsychopharmacology. 2018; 43(12):2399-2407.
PMID: 30305739
PMC: 6180085.
DOI: 10.1038/s41386-018-0209-3.
Role of monoaminergic systems and ambient temperature in bath salts constituent 3,4-methylenedioxypyrovalerone (MDPV)-elicited hyperthermia and locomotor stimulation in mice.
Gannon B, Williamson A, Rice K, Fantegrossi W
Neuropharmacology. 2017; 134(Pt A):13-21.
PMID: 28887185
PMC: 5837893.
DOI: 10.1016/j.neuropharm.2017.09.004.
Locomotor and reinforcing effects of pentedrone, pentylone and methylone in rats.
Javadi-Paydar M, Nguyen J, Vandewater S, Dickerson T, Taffe M
Neuropharmacology. 2017; 134(Pt A):57-64.
PMID: 28882561
PMC: 5835165.
DOI: 10.1016/j.neuropharm.2017.09.002.
Relative reinforcing effects of second-generation synthetic cathinones: Acquisition of self-administration and fixed ratio dose-response curves in rats.
Gannon B, Galindo K, Mesmin M, Sulima A, Rice K, Collins G
Neuropharmacology. 2017; 134(Pt A):28-35.
PMID: 28811192
PMC: 5809320.
DOI: 10.1016/j.neuropharm.2017.08.018.
Reinforcing effects of abused 'bath salts' constituents 3,4-methylenedioxypyrovalerone and α-pyrrolidinopentiophenone and their enantiomers.
Gannon B, Rice K, Collins G
Behav Pharmacol. 2017; 28(7):578-581.
PMID: 28570297
PMC: 5599337.
DOI: 10.1097/FBP.0000000000000315.
Active vaccination attenuates the psychostimulant effects of α-PVP and MDPV in rats.
Nguyen J, Bremer P, Ducime A, Creehan K, Kisby B, Taffe M
Neuropharmacology. 2016; 116:1-8.
PMID: 27956054
PMC: 5385148.
DOI: 10.1016/j.neuropharm.2016.12.005.
Self-administration and behavioral economics of second-generation synthetic cathinones in male rats.
Huskinson S, Naylor J, Townsend E, Rowlett J, Blough B, Freeman K
Psychopharmacology (Berl). 2016; 234(4):589-598.
PMID: 27896377
PMC: 5266647.
DOI: 10.1007/s00213-016-4492-6.
Designer Drugs: A Synthetic Catastrophe.
Fratantonio J, Andrade L, Febo M
J Reward Defic Syndr. 2016; 1(2):82-86.
PMID: 27617301
PMC: 5013729.
DOI: 10.17756/jrds.2015-014.
4-Methoxy-α-PVP: in silico prediction, metabolic stability, and metabolite identification by human hepatocyte incubation and high-resolution mass spectrometry.
Ellefsen K, Wohlfarth A, Swortwood M, Diao X, Concheiro M, Huestis M
Forensic Toxicol. 2016; 34:61-75.
PMID: 26793277
PMC: 4705136.
DOI: 10.1007/s11419-015-0287-4.
In vitro, in vivo and in silico metabolic profiling of α-pyrrolidinopentiothiophenone, a novel thiophene stimulant.
Swortwood M, Carlier J, Ellefsen K, Wohlfarth A, Diao X, Concheiro-Guisan M
Bioanalysis. 2015; 8(1):65-82.
PMID: 26648097
PMC: 5493968.
DOI: 10.4155/bio.15.237.
The Effects of 4-Methylethcathinone on Conditioned Place Preference, Locomotor Sensitization, and Anxiety-Like Behavior: A Comparison with Methamphetamine.
Xu P, Qiu Y, Zhang Y, Bai Y, Xu P, Liu Y
Int J Neuropsychopharmacol. 2015; 19(4).
PMID: 26612552
PMC: 4851266.
DOI: 10.1093/ijnp/pyv120.
Structural Modification of the Designer Stimulant α-Pyrrolidinovalerophenone (α-PVP) Influences Potency at Dopamine Transporters.
Kolanos R, Sakloth F, Jain A, Partilla J, Baumann M, Glennon R
ACS Chem Neurosci. 2015; 6(10):1726-31.
PMID: 26217965
PMC: 5349767.
DOI: 10.1021/acschemneuro.5b00160.
Comparative Behavioral Pharmacology of Three Pyrrolidine-Containing Synthetic Cathinone Derivatives.
Gatch M, Dolan S, Forster M
J Pharmacol Exp Ther. 2015; 354(2):103-10.
PMID: 25998047
PMC: 4518071.
DOI: 10.1124/jpet.115.223586.
In vivo potency and efficacy of the novel cathinone α-pyrrolidinopentiophenone and 3,4-methylenedioxypyrovalerone: self-administration and locomotor stimulation in male rats.
Aarde S, Creehan K, Vandewater S, Dickerson T, Taffe M
Psychopharmacology (Berl). 2015; 232(16):3045-55.
PMID: 25925780
PMC: 4515201.
DOI: 10.1007/s00213-015-3944-8.